KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monster Beverage (MNST) Cash & Equivalents (2016 - 2025)

Monster Beverage (MNST) has disclosed Cash & Equivalents for 17 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 36.19% to $2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 36.19% increase, with the full-year FY2025 number at $2.1 billion, up 36.19% from a year prior.
  • Cash & Equivalents was $2.1 billion for Q4 2025 at Monster Beverage, down from $2.3 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.6 billion in Q1 2024 to a low of $1.2 billion in Q1 2021.
  • A 5-year average of $1.8 billion and a median of $1.7 billion in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 75.78% in 2023, then crashed 33.27% in 2024.
  • Monster Beverage's Cash & Equivalents stood at $1.3 billion in 2021, then decreased by 1.46% to $1.3 billion in 2022, then soared by 75.78% to $2.3 billion in 2023, then plummeted by 33.27% to $1.5 billion in 2024, then soared by 36.19% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for MNST's Cash & Equivalents are $2.1 billion (Q4 2025), $2.3 billion (Q3 2025), and $1.9 billion (Q2 2025).